TCL Archive In Brief: 163 PIs Hold Both Contracts, Grants; Hopkins Scientists Questions Retrospective Diet Studies August 27, 1976
TCL Archive Most of NCI’s $60 Million Increase In FY95 will fund Mandatory Raise In Prevention October 14, 1994
TCL Archive Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment. July 30, 2004
TCL Archive ODAC Supports Approval For Taxotere In Breast Cancer, Hycamtin In Lung Cancer June 5, 1998
